09/23
2021

The Role of Biosimilars for Supportive Care in the COVID-19 Era

6:00 pm - 7:00 pm
Online
Alison Stebbings, PharmD, BCOP and Adrian Zobinw PharmD, BCOP
Click link above to register

September 23, 2021, 6pm to 7 pm Virtual Live: Boston MA

Audience:        Accredited for Pharmacists

                         Other interested health care professionals welcome

Credits:           1 Contact Hour 0.1 CEU will be awarded Knowledge-based

Presenters:      Alison Stebbings, PharmD, BCOP-Clinical Pharmacy Specialist-Oncology

                          Adrian Zobinw PharmD, BCOP-Clinical Pharmacy Specialist-Oncology

Pharmacist Learning Objectives:  0837-9999-21-175-L01-P

After attending this program, participants will be able to:

  1. Describe the differences between the FDA approval process for a reference product vs. a biosimilar product
  2. Identify potential barriers for biosimilar implementation
  3. Defend arguments supporting the economic impact of biosimilar conversions
  4. When provided a patient case, indicate whether or not the use of a GCSF biosimilar product would be appropriate for that patient in the COVID-19 era

Requirements for Receiving CE Credit:

  • Successful completion of post-presentation questions
  • Participation at live program
  • Complete program evaluation form

Registration Fee:  Free for MaSHP members -- $10 for non-members